Voyager Therapeutics, Inc. (FRA:VT6)

Voyager Therapeutics Statistics

Total Valuation

FRA:VT6 has a market cap or net worth of EUR 188.92 million. The enterprise value is 24.93 million.

Market Cap	188.92M
Enterprise Value	24.93M

Important Dates

The next estimated earnings date is Friday, March 6, 2026.

Earnings Date	Mar 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	55.60M
Shares Outstanding	n/a
Shares Change (YoY)	+4.78%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	47.17%
Float	50.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.08
PB Ratio	1.01
P/TBV Ratio	1.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.23
EV / Sales	0.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.25

Financial Position

The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.17.

Current Ratio	6.19
Quick Ratio	6.00
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.32
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.09% and return on invested capital (ROIC) is -27.65%.

Return on Equity (ROE)	-46.09%
Return on Assets (ROA)	-24.53%
Return on Invested Capital (ROIC)	-27.65%
Return on Capital Employed (ROCE)	-55.46%
Revenue Per Employee	155,178
Profits Per Employee	-628,234
Employee Count	172
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:VT6 has paid 612,804 in taxes.

Income Tax	612,804
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-49.14%
50-Day Moving Average	3.73
200-Day Moving Average	3.14
Relative Strength Index (RSI)	43.75
Average Volume (20 Days)	101

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.63

Income Statement

In the last 12 months, FRA:VT6 had revenue of EUR 26.69 million and -108.06 million in losses. Loss per share was -1.85.

Revenue	26.69M
Gross Profit	-87.78M
Operating Income	-119.50M
Pretax Income	-107.44M
Net Income	-108.06M
EBITDA	-116.07M
EBIT	-119.50M
Loss Per Share	-1.85

Balance Sheet

The company has 178.07 million in cash and 32.70 million in debt, giving a net cash position of 162.49 million.

Cash & Cash Equivalents	178.07M
Total Debt	32.70M
Net Cash	162.49M
Net Cash Per Share	n/a
Equity (Book Value)	187.36M
Book Value Per Share	3.38
Working Capital	156.90M

Cash Flow

In the last 12 months, operating cash flow was -99.49 million and capital expenditures -1.81 million, giving a free cash flow of -101.30 million.

Operating Cash Flow	-99.49M
Capital Expenditures	-1.81M
Free Cash Flow	-101.30M
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-447.73%
Pretax Margin	-402.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:VT6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.78%
Shareholder Yield	-4.78%
Earnings Yield	-57.20%
FCF Yield	-53.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:VT6 has an Altman Z-Score of -0.6 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.6
Piotroski F-Score	1